ASH 2024: Expert Discusses Challenges, Future Research Opportunities With Bispecific Antibodies in Multiple Myeloma

by | Dec 13, 2024 | Myeloma News | 0 comments

Source: Pharmacy Times articles

Ira Zackon, MD, explains where future research lies regarding the implementation of bispecific antibodies in community oncology settings.
Read More

You must be logged in to post a comment.